Citation only
via OpenAlex
Pharmacology of NAD+boosters
Nady Braidy, Perminder Singh Sachdev
Elsevier eBooks · 2023 · ▲ 1 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/b978-0-12-823679-6.00005-9
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Braidy, N., & Sachdev, P.S. (2023). Pharmacology of NAD+boosters. <em>Elsevier eBooks</em>. https://doi.org/10.1016/b978-0-12-823679-6.00005-9
Vancouver
Braidy N, Sachdev PS. Pharmacology of NAD+boosters. Elsevier eBooks. 2023. doi:10.1016/b978-0-12-823679-6.00005-9.
BibTeX
@article{nady2023Pharma,
title = {Pharmacology of NAD+boosters},
author = {Nady Braidy and Perminder Singh Sachdev},
journal = {Elsevier eBooks},
year = {2023},
doi = {10.1016/b978-0-12-823679-6.00005-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
NAD+ exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA
Potential significance of NAD+ biology translational research in super-aged Japan
Nature Reviews Drug Discovery 2019
Open access · OA
Lysosomes as a therapeutic target
Springer eBooks 2022
Citation only
NAD+ Metabolism in Aging
EMBO Reports 2023
Preprint · OA
Lysosomes in senescence and aging
Frontiers in aging
Open access · OA